Compounds > 4-chloromethylbiphenyl
Page last updated: 2024-12-05

4-chloromethylbiphenyl

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-chloromethylbiphenyl: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID15463
SCHEMBL ID1071609
MeSH IDM0103859

Synonyms (49)

Synonym
nsc 16277
4-(chloromethyl)-1'-biphenyl
brn 1863327
4-chloromethylbiphenyl
einecs 216-786-5
4-cmb
4-(chloromethyl)-1,1'-biphenyl
biphenyl, 4-(chloromethyl)-
nsc16277
1667-11-4
p-phenylbenzyl chloride
4-(chloromethyl)biphenyl
4-phenylbenzyl chloride
nsc-16277
1,1'-biphenyl, 4-(chloromethyl)-
4-phenylbenzyl chloride, 98%
1-(chloromethyl)-4-phenylbenzene
hlqzcrveeqknms-uhfffaoysa-
inchi=1/c13h11cl/c14-10-11-6-8-13(9-7-11)12-4-2-1-3-5-12/h1-9h,10h2
A3695
4-biphenylmethyl chloride
unii-3f1186uu0m
3f1186uu0m ,
4-05-00-01861 (beilstein handbook reference)
AKOS008965475
BP-11388
FT-0633748
chloromethylbiphenyl, 4-
SCHEMBL1071609
4-chloromethyl-biphenyl
(1,1'-biphenyl)-4-ylmethyl chloride
4- chloromethylbiphenyl
4-chloromethyl biphenyl
biphenyl-4-ylmethyl chloride
1-(chloromethyl)4-phenylbenzene
4-phenyl-benzylchloride
1-chloromethyl-4-phenyl-benzene
4-phenylbenzylchloride
4-phenyl benzyl chloride
mfcd00000917
SY015108
4cmb
4-(chloromethyl)-1,1'-biphenyl #
biphenyl, 4-(chloromethyl)-,
DTXSID6075190
AS-15672
EN300-09858
Q27257137
Z56347092
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (3)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.06

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.06 (24.57)
Research Supply Index4.39 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.06)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other80 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
cytarabine
[no description available]		1.9610beta-D-arabinoside;
monosaccharide derivative;
pyrimidine nucleoside		antimetabolite;
antineoplastic agent;
antiviral agent;
immunosuppressive agent
benzyl chloride
benzyl chloride: RN given refers to unlabeled cpd. chlorophenylmethane : A chlorohydrocarbon that is phenylmethane substituted by a chloro group at unspecified position.. benzyl chloride : A member of the class of benzyl chlorides that is toluene substituted on the alpha-carbon with chlorine.		2.3720benzyl chlorides
4-hydroxymethylbiphenyl
4-hydroxymethylbiphenyl: structure given in first source		6.9610
ConditionIndicatedRelationship StrengthStudiesTrials
Abnormalities, Autosome
[description not available]		01.9610
Kaposi Disease
[description not available]		01.9610
Xeroderma Pigmentosum
A rare, pigmentary, and atrophic autosomal recessive disease. It is manifested as an extreme photosensitivity to ULTRAVIOLET RAYS as the result of a deficiency in the enzyme that permits excisional repair of ultraviolet-damaged DNA.		01.9610